US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Shuttle Pharmaceuticals Holdings Inc (SHPH)
Shuttle Pharmaceuticals Holdings Inc (SHPH) ニュース

SHPH

Shuttle Pharmaceuticals (SHPH)

Shuttle Pharmaceuticals Holdings Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SHPH

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/07/19	22 : 00	GlobeNewswire Inc.	Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/07/17	05 : 59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/06/18	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/06/18	22 : 00	GlobeNewswire Inc.	Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/06/10	19 : 12	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/05/23	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/05/23	05 : 15	GlobeNewswire Inc.	Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/05/14	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/05/14	22 : 00	GlobeNewswire Inc.	Shuttle Pharma Provides First Quarter 2024 Corporate Update	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/05/14	06 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/04/24	05 : 15	GlobeNewswire Inc.	Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/03/22	22 : 00	PR Newswire (US)	Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/03/09	08 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/03/05	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/02/13	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/02/13	22 : 00	PR Newswire (US)	Shuttle Pharma Announces Its Intent to Pursue a Rights Offering	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/02/06	06 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/01/24	06 : 30	PR Newswire (US)	Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/01/08	23 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/01/08	23 : 00	PR Newswire (US)	Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2024/01/03	07 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/12/21	11 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/12/20	07 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/12/11	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/12/11	23 : 00	PR Newswire (US)	Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/11/30	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/11/14	23 : 00	PR Newswire (US)	Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/11/14	06 : 21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/10/31	22 : 00	PR Newswire (US)	Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc
2023/10/31	06 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SHPH	Shuttle Pharmaceuticals Holdings Inc

Showing the most relevant articles for your search:NASDAQ:SHPH

1 2 3 4 次へ >>

US Dollar vs Euro

BNP Paribas (QX)

Bank of America

American Express

JP Morgan Chase

Deutsche Telekom (QX)

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約